6/4
08:04 am
eldn
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
6/3
04:19 pm
eldn
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation [Yahoo! Finance]
Medium
Report
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation [Yahoo! Finance]
6/3
04:01 pm
eldn
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Low
Report
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
5/27
12:44 pm
eldn
Eledon Pharmaceuticals (ELDN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals (ELDN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
5/22
01:40 pm
eldn
Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals, Inc. (ELDN) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
5/14
02:01 pm
eldn
Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
5/12
02:27 pm
eldn
First human to receive transplanted pig kidney dies [Reuters]
Medium
Report
First human to receive transplanted pig kidney dies [Reuters]
5/9
07:40 am
eldn
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
5/9
07:30 am
eldn
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Low
Report
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
5/9
07:06 am
eldn
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress [Yahoo! Finance]
5/9
07:00 am
eldn
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
Low
Report
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
5/7
10:54 am
eldn
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target raised by analysts at HC Wainwright from $13.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target raised by analysts at HC Wainwright from $13.00 to $16.00. They now have a "buy" rating on the stock.
5/7
07:16 am
eldn
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement [Yahoo! Finance]
5/7
07:05 am
eldn
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
High
Report
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
5/7
07:00 am
eldn
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
High
Report
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
3/28
04:19 pm
eldn
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results [Yahoo! Finance]
3/28
04:01 pm
eldn
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Medium
Report
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
3/25
05:06 pm
eldn
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection [Yahoo! Finance]
3/25
04:56 pm
eldn
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Low
Report
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
3/22
08:07 am
eldn
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
3/21
11:34 am
eldn
UPDATE 1-US surgeons perform first pig-to-human kidney transplant [Yahoo! Finance]
Medium
Report
UPDATE 1-US surgeons perform first pig-to-human kidney transplant [Yahoo! Finance]
3/21
10:35 am
eldn
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human [Yahoo! Finance]
3/21
10:31 am
eldn
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Medium
Report
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
3/21
09:38 am
eldn
eGenesis Announces World's First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient [Yahoo! Finance]
Medium
Report
eGenesis Announces World's First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient [Yahoo! Finance]